Cause of death, by non-communicable diseases, ages 0-4, male in Tonga
Tonga: Cause of death, by non-communicable diseases, ages 0-4, male was 38.6% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 0-4, male in Tonga, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 0-4.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 0-4, male in Tonga stood at 38.6%. That is the highest value across all 6 years on record.
That represents a change of up 0.5% on the previous year and up 3.4% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4, male in Tonga peaked at 38.6% in 2021 and was at its lowest, 34.0%, in 2000.
Tonga ranks 54th of 185 countries on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, ages 0-4, male in Tonga, year by year
| Year | % of total male deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 34.0% | — |
| 2010 | 37.4% | +9.8% |
| 2015 | 37.9% | +1.5% |
| 2019 | 38.1% | +0.4% |
| 2020 | 38.4% | +0.9% |
| 2021 | 38.6% | +0.5% |
Tonga compared with similar countries
- Tonga's 38.6% is above the median for upper middle income countries, which is 31.9%, 1.2× the median. (55 countries reporting)
- Tonga's 38.6% is above the median for East Asia & Pacific, which is 31.4%, 1.2× the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 34.0% | 34.0% | 34.0% | 1 |
| 2010s | 37.8% | 37.4% | 38.1% | 3 |
| 2020s | 38.5% | 38.4% | 38.6% | 2 |
Countries ranked near Tonga
More health data for Tonga
- Un projection of annual infant deaths, annual growth rate -33.33 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 2.33 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 834.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.42 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0535 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.36 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4, male in Tonga?
- Cause of death, by non-communicable diseases, ages 0-4, male in Tonga was 38.6% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4, male recorded in Tonga?
- The highest recorded value was 38.6% in 2021.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4, male recorded in Tonga?
- The lowest recorded value was 34.0% in 2000.
- How does Tonga rank for cause of death, by non-communicable diseases, ages 0-4, male?
- Tonga ranks 54th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4, male rising or falling in Tonga?
- Over the last ten years it is up 3.4%. The long-run trend across the full record is rising.
- Where does this Tonga data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.